|
| Total bilirubin (mg/dL) | D/T*(%) | Severity ALT (35 U/L) | AST/ALT ratio | Bili/urine | Urobilinogen/urine | Severity GGT (38 U/L) |
| Hematology diseases | ≤7 | ≤20 | ≤1 | ≥2 | − | Normal/increase | ≤1 |
| Hematoma/hemorrhagy | ≤7 | ≤60 | ≤2.5 | ≥2 | − | Normal/increase | ≤2.5 |
| Cardiac diseases | ≤7 | ≤60 | ≤2.5 | 1 - 2 | −/+ | Normal/increase | ≤2.5 |
| Sepsis | ≤7 | >60 | ≤2.5 | ≥2 | − | Normal | >5 |
| Cirrhosis | ≤7 | >60 | ≤2.5 | ≥2 | −/+ | Normal/increase | ≤5 |
| Liver tumor | ≤7 | >60 | ≤2.5 | ≥2 | −/+ | Normal/increase | ≤5 |
| Pancreatic and biliary tract diseases | >7 | >60 | ≤5.0 | 1 - 2 | +++ | Normal | >5 |
| Cholangitis | >7 | >60 | ≤5.0 | 1 - 2 | ++ | Normal | >5 |
| Hepatitis | >7 | >60 | >5 | <1 | ++ | Normal | ≤5 |